α-Methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone

Human Pathology

Volumn 34, Issue 3, 2003, Pages 228-233

  Leav, Irwin ^a   McNeal, John E ^b   Ho, Shuk mei ^b   Jiang, Zhong ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Prostatic carcinoma; Transition zone; Methylacyl CoA racemase

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; FATTY ACID; FATTY ACID DERIVATIVE; KERATIN ANTIBODY; MOLECULAR MARKER; MONOCLONAL ANTIBODY; RACEMASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TRANSITION ZONE CANCER; TUMOR DIFFERENTIATION;

EID: 0037343327     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.42     Document Type: Article

References (32)

1. McNeal JE: Origin and development of carcinoma in the prostate. Cancer 23:24-34, 1969
2. McNeal JE, Redwine EA, Freiha FS, et al: Zonal distribution of prostatic adenocarcinoma: Correlation with histologic pattern and direction of spread. Am J Surg Pathol 12:897-906, 1988
3. McNeal JE, Cohen RJ, Brooks JD: Role of cytologic criteria in the histologic diagnosis of Gleason grade 1 prostatic adenocarcinoma. HUM PATHOL 32:441-446, 2001
4. Gleason DF: Histological grading of prostate cancer: A perspective. HUM PATHOL 23:173-178, 1992
5. Young RH, Srigley JR, Amin MB, et al: Carcinoma of the prostate gland, in Rosai J (ed): Atlas of Tumor Pathology. Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra, and Penis. Washington, DC, Armed Forces Institute of Pathology, 2000, p 132
6. McNeal JE: Origin and evolution of benign prostatic enlargement. Invest Urol 15:340-345, 1978
7. Greenwald P, Kirmas V, Polan AK, et al: Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53:335-340, 1974
8. Armenian HK, Lilienfeld AM, Diamond EL, et al: Relation between benign prostatic hyperplasia and cancer of the prostate: A prospective and retrospective study. Lancet 2:115-117, 1974
9. Guess HA: Benign prostatic hyperplasia and prostate cancer. Epidemiol Rev 23:152-158, 2001
10. Ornstein DK, Rao GS, Smith DS, et al: The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate. J Urol 157:880-883, 1997
11. Bostwick DG, Cooner WH, Denis L, et al: The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70(suppl 1):291-301, 1992
12. McNeal JE, Bostwick DG: Intraductal dysplasia: A premalignant lesion of the prostate. HUM PATHOL 17:64-71, 1986
13. Bostwick DG: High-grade intraepithelial neoplasia: The most likely precursor of prostate cancer. Cancer 75:1823-1836, 1995
14. Bostwick DG, Qian J: Atypical adenomatous hyperplasia of the prostate: Relationship with carcinoma in 217 whole-mount prostatectomies. Am J Surg Pathol 19:506-518, 1995
15. Bostwick DG, Srigley J, Grignon D, et al: Atypical adenomatous hyperplasia of the prostate: Morphological criteria for its distinction from well-differentiated carcinoma. HUM PATHOL 24:819-832, 1993
16. Epstein JI: Adenosis (atypical, adenomatous hyperplasia): Histology and relationship to carcinoma. Pathol Res Pract 191:888-898, 1995
17. Xu J, Stolk JA, Zhang X, et al: Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60:1677-1682, 2000
18. Ferdinandusse S, Denis S, Ijlst L, et al: Subcellular localization and physiological role of α-methylacyl-CoA racemase. J Lipid Res 41:1890-1896, 2000
19. Jiang Z, Woda BA, Rock KL, et al: P504S: A new molecular marker for the detection of prostate cancer. Am J Surg Pathol 25:1397-1404, 2001
20. Luo J, Zha S, Gage W, et al: α-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 62:2220-2226, 2002
21. Zhou M, Cinnaiyan AM, Kleer CG, et al: Alpha-methylacyl-CoA racemase: A novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26:926-931, 2002
22. Rubin MA, Zhou M, Dhanasekaran SM, et al: Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287:1662-1670, 2002
23. Brawer MK, Peehl DM, Stamey TA, et al: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 45:3663-3667, 1985
24. Signoretti S, Waltregny D, Dilks J, et al: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 157:1769-1775, 2000
25. Pacelli A, Bostwick DG: Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens. Urology 50:355-359, 1997
26. Harvei S, Skjorten FJ, Robsahm TE, et al: Is prostatic intraepithelial neoplasia in the transition/central zone a true precursor of cancer? A long-term retrospective study in Norway. Br J Cancer 78:46-49, 1998
27. Yang XJ, Wu CL, Woda BA, et al: Expression of P504S in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26:921-925, 2002
28. Wanders RJ, Vreken P, Ferdinanduesse S, et al: Peroxisome fatty acid α and β oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 29:250-267, 2001
29. Ockner RK, Kaikaus RM, Bass NM: Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: Review and hypothesis. Hepatology 18:669-676, 1993
30. Swinnen JV, Verhoeven G: Androgens and the control of lipid metabolism in human prostate cancer cells. J Ster Biochem Mol Biol 65:191-198, 1998
31. Heemers H, Maes B, Foufelle F, et al: Androgens simulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15:1817-1828, 2001
32. Pizer ES, Pflug BR, Bova GS, et al: Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression. Prostate 47:102-110, 2001